Concepedia

Author

Fidi Koppel

Technion – Israel Institute of Technology

Also Known As

F Koppel, F., Koppel, Fidi Koppel, Hiba Zayyad, Yehuda Carmeli

22

Publications

1.6K

Citations

12

H-Index

13

Concepts

All Affiliations

Technion – Israel Institute of TechnologyTel Aviv UniversityRabin Medical CenterRambam Health Care CampusUniversity of Modena and Reggio Emilia
FK

About

Fidi Koppel is an author at Technion – Israel Institute of Technology specializing in microbiology, medicine, and clinical microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

679

2

Microbiology

3

3

679

3

Health Sciences

2

2

668

4

Antibiotics

2

2

668

5

Clinical Microbiology

2

2

668

Fidi Koppel

×

9

Publications

1.2K

Citations

9

H-Index

YearCitations

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni,

The Lancet Infectious Diseases

2018

593

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Dafna Yahav, Erica Franceschini, Fidi Koppel,

Clinical Infectious Diseases

2018

387

Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

Amir Nutman, Jonathan Lellouche, Elizabeth Temkin,

Clinical Microbiology and Infection

2020

75

Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis

‪Adi Turjeman‬‏, Elodie von Dach, José Molina,

EClinicalMedicine

2022

49

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

Yaakov Dickstein, Leonard Leibovici, Dafna Yahav,

BMJ Open

2016

45

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii

Hadas Kon, Amichay Hameir, Amir Nutman,

Microbiology Spectrum

2023

23

Piperacillin–tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)

Roni Bitterman, Fidi Koppel, Cristina Mussini,

BMJ Open

2021

22

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection

Jessica Howard‐Anderson, Weixiao Dai, Dafna Yahav,

Open Forum Infectious Diseases

2022

15

Indicator bacteria for fecal pollution in the littoral zone of Lake Kinneret

Talya Bergstein-Ben Dan, Fidi Koppel

Water Research

1992

11

Page 1